GLP-1 Drugs: What Five Years of Data Actually Shows
Semaglutide cut cardiovascular events by 20 percent in the SELECT trial, but a 2026 real-world study found the benefit evaporates within 18 months of stopping. The drugs work. The question is whether they work forever or just while you take them.